These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 11277695

  • 1. Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.
    Smahel M, Síma P, Ludvíková V, Vonka V.
    Virology; 2001 Mar 15; 281(2):231-8. PubMed ID: 11277695
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.
    Smahel M, Poláková I, Pokorná D, Ludvíková V, Dusková M, Vlasák J.
    Int J Oncol; 2008 Jul 15; 33(1):93-101. PubMed ID: 18575754
    [Abstract] [Full Text] [Related]

  • 5. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK, Cheng SC, Sin FW, Xie Y.
    Vaccine; 2004 Dec 16; 23(5):629-38. PubMed ID: 15542183
    [Abstract] [Full Text] [Related]

  • 6. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.
    Vaccine; 2006 Apr 05; 24(15):2880-93. PubMed ID: 16472545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q, Cheung YK, Cheng SC, Wang XH, Shi M, Hu MH, Yong X.
    Gynecol Oncol; 2007 Jan 05; 104(1):199-206. PubMed ID: 17049969
    [Abstract] [Full Text] [Related]

  • 11. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
    Kim JW, Hung CF, Juang J, He L, Kim TW, Armstrong DK, Pai SI, Chen PJ, Lin CT, Boyd DA, Wu TC.
    Gene Ther; 2004 Jun 05; 11(12):1011-8. PubMed ID: 14985791
    [Abstract] [Full Text] [Related]

  • 12. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY, Cheng WF.
    Gynecol Oncol; 2007 Dec 05; 107(3):404-12. PubMed ID: 17905417
    [Abstract] [Full Text] [Related]

  • 13. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S, Duskova M, Mackova J, Pokorna D, Jinoch P, Smahel M.
    Oncol Rep; 2005 Feb 05; 13(2):311-7. PubMed ID: 15643517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.
    Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Müller M.
    Virology; 2002 Mar 01; 294(1):47-59. PubMed ID: 11886264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.
    Gene Ther; 2001 Jan 01; 8(2):128-38. PubMed ID: 11313782
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.